KATIE LITTEKEN: Open Payments
NPI 1447598560 · WICHITA FALLS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$331 in 10 payments from 8 companies in 2025. Trend: 2023 $967 · 2024 $468 · 2025 $331
Food & beverage: $288Education: $43
| Company | Payments | Amount |
|---|---|---|
| Myriad Genetic Laboratories, Inc. | 1 | $121 |
| AstraZeneca Pharmaceuticals LP | 1 | $43 |
| Janssen Biotech, Inc. | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| Stemline Therapeutics Inc. | 1 | $25 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: MYRISK, ENHERTU, Fabhalta, Orserdu, Odomzo, RYBREVANT, OPDIVO, ERLEADA.
Industry payments across TX — which companies pay providers there.
